Study of BEST1 Vitelliform Macular Dystrophy

Plain-language summary

This natural history study examines how the disease progresses over time in people with BEST1-associated vitelliform macular dystrophy. It enrolls people diagnosed with this BEST1-related condition by retinal specialists. It is a study without an assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Columbia University

Intervention

Natural History Study

Start date

3/30/2021

Estimated completion

5/31/2026

Countries

United States, France, Germany

Related genes

Locations

• New York, United States
• Paris, France
• Tübingen, Germany

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Ability to provide informed consent
* Diagnosis of BEST1-associated VMD by study physician, who are trained retinal specialists in the university clinic Must be able to commit to 4 follow-up study visits (3 years)

Exclusion Criteria:

* Systemic condition that prevents the participant from undergoing the exams